Prof Robin Weiss


Personal Profile

Name: Robin Weiss Email:
Title: Prof Tel: +44 (20) 3108 2137
Department: Div of Infection & Immunity Fax: +44 (02) 3108 2123
Position: Professor of Virol Oncology Address: Cruciform Building, Gower Street, London, London, WC1E 6BT
Research Domain: Global Health, Infection, Immunology & Inflammation, Personalised Medicine Web Page: Personal Web Page


Research Description

Our laboratory mainly addresses the immune response to HIV and why no successful vaccine to HIV has yet been developed. We work on antibodies to HIV particularly those that neutralize the infectivity of the virus. We work with phage libaries derived from single-chain antibodies of llamas among other antibodies. We are also interested in the cell tropism and virulence of HIV, and in human genetic factors that determine the risk of infection by HIV and the rate of progression to AIDS. We have also adapted techniques used to study HIV neutralizing antibodies to other emerging virus infections in particular SARS, H5N1 influenza and rabies. I take an interest in the history of the appearance of human infectious diseases and the impact that they have had in the past and may well in the future. Our research is funded by the MRC, the European Union and the Bill & Melinda Gates Foundation.

Research Activities

Humoral immunity to HIV, emerging infections

cellular factors in virus infection

Education Description

Lectures and seminars to undergraduates and postgraduates on the above topics.

UCL Collaborators

Dr Ariberto Fassati; Prof Stephen Caddick; Dr Yasu Takeuchi; Prof Chris Boshoff; Prof Paul Kellam

External Collaborators



    • McCoy LE, Rutten L, Frampton D, Anderson I, Granger L, Bashford-Rogers R, Dekkers G, Strokappe NM, Seaman MS, Koh W, Grippo V, Kliche A, Verrips T, Kellam P, Fassati A, Weiss RA (2014). Molecular evolution of broadly neutralizing llama antibodies to the CD4-binding site of HIV-1.. PLoS Pathog, 10(12), e1004552 - . doi:10.1371/journal.ppat.1004552
    • Mccoy LE, Groppelli E, Blanchetot C, de Haard H, Verrips T, Rutten L, Weiss RA, Jolly C (2014). Neutralisation of HIV-1 cell-cell spread by human and llama antibodies. RETROVIROLOGY, 11, - . doi:10.1186/s12977-014-0083-y
    • Murchison EP, Wedge DC, Alexandrov LB, Fu B, Martincorena I, Ning Z, Tubio JM, Werner EI, Allen J, De Nardi AB, Donelan EM, Marino G, Fassati A, Campbell PJ, Yang F, Burt A, Weiss RA, Stratton MR (2014). Transmissible [corrected] dog cancer genome reveals the origin and history of an ancient cell lineage.. Science, 343(6169), 437 - 440. doi:10.1126/science.1247167
    • Chiodi F, Weiss RA (2014). Human immunodeficiency virus antibodies and the vaccine problem.. J Intern Med, 275(5), 444 - 455. doi:10.1111/joim.12225
    • Weiss RA (2014). Immunotherapy for HIV Infection.. N Engl J Med, 370(4), 379 - 380. doi:10.1056/NEJMcibr1314577
    • Berkhout B, Bodem J, Erlwein O, Herchenröder O, Khan AS, Lever AM, Lindemann D, Linial ML, Löchelt M, McClure MO, Scheller C, Weiss RA (2014). Obituary: Axel Rethwilm (1959-2014).. Retrovirology, 11, 85 - . doi:10.1186/s12977-014-0085-9


    • Weiss R (2013). Influence of Duffy antigen receptor for chemokines on HIV infection. RETROVIROLOGY, 10, S6 - S7.
    • Weiss RA, Gherardi E (2013). Michael stoker 1918-2013.. Cell, 155(3), 493 - 494. doi:10.1016/j.cell.2013.10.005
    • Weiss RA (2013). On the concept and elucidation of endogenous retroviruses.. Philos Trans R Soc Lond B Biol Sci, 368(1626), 20120494 - . doi:10.1098/rstb.2012.0494
    • McCoy LE, Weiss RA (2013). Neutralizing antibodies to HIV-1 induced by immunization.. J Exp Med, 210(2), 209 - 223. doi:10.1084/jem.20121827
    • Weiss RA (2013). Thirty years on: HIV receptor gymnastics and the prevention of infection.. BMC Biol, 11, 57 - . doi:10.1186/1741-7007-11-57
    • Hulsik DL, Liu Y-Y, Strokappe NM, Battella S, El Khattabi M, McCoy LE, Sabin C, Hinz A, Hock M, Macheboeuf P, Bonvin AMJJ, Langedijk JPM, Davis D, Quigley AF, Aasa-Chapman MMI, Seaman MS, Ramos A, Poignard P, Favier A, Simorre J-P, Weiss RA, Verrips CT, Weissenhorn W, Rutten L (2013). A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition. PLOS PATHOGENS, 9(3), - . doi:10.1371/journal.ppat.1003202
    • Weiss RA, Stoye JP (2013). Virology. Our viral inheritance.. Science, 340(6134), 820 - 821. doi:10.1126/science.1235148


    • Weiss R (2012). AIDS at 30: A History. NATURE, 482(7386), 468 - 468.
    • Weiss R (2012). The Origins of AIDS. NATURE, 482(7386), 468 - 468.
    • Weiss R (2012). Travels with a Tangerine: A Journey in the Footnotes of Ibn Battutah. NATURE, 487(7405), 35 - 35.
    • Weiss R (2012). The AIDS Conspiracy: Science Fights Back. NATURE, 482(7386), 468 - 468.
    • Ndung'u T, Weiss RA (2012). On HIV diversity.. AIDS, 26(10), 1255 - 1260. doi:10.1097/QAD.0b013e32835461b5
    • McCoy LE, Quigley AF, Strokappe NM, Bulmer-Thomas B, Seaman MS, Mortier D, Rutten L, Chander N, Edwards CJ, Ketteler R, Davis D, Verrips T, Weiss RA (2012). Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization.. J Exp Med, 209(6), 1091 - 1103. doi:10.1084/jem.20112655
    • Strokappe N, Szynol A, Aasa-Chapman M, Gorlani A, Forsman Quigley A, Hulsik DL, Chen L, Weiss R, de Haard H, Verrips T (2012). Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C.. PLoS One, 7(3), e33298 - . doi:10.1371/journal.pone.0033298
    • de Silva TI, Aasa-Chapman M, Cotten M, Hué S, Robinson J, Bibollet-Ruche F, Sarge-Njie R, Berry N, Jaye A, Aaby P, Whittle H, Rowland-Jones S, Weiss R (2012). Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes.. J Virol, 86(2), 930 - 946. doi:10.1128/JVI.06126-11
    • McCoy LE, Rutten L, Dekkers G, Blanchetot C, Strokappe NM, Forsman-Quigley A, Seaman MS, de Haard H, Verrips T, Weiss RA (2012). Broad and potent neutralization of HIV-1 by human-llama fusion antibodies derived from immunized llamas. RETROVIROLOGY, 9, - . doi:10.1186/1742-4690-9-S2-P94
    • Weissenhorn W, Hulsik DL, Hock M, Liu YY, Strokappe NM, Khattabi ME, Langedijk JP, McCoy LE, Forsman-Quigley A, Aasa-Chapman MM, Weiss RA, Verrips TC, Rutten L (2012). A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 determinant for neutralization but not for antigen recognition. RETROVIROLOGY, 9, - . doi:10.1186/1742-4690-9-S2-P317
    • Gorlani A, Brouwers J, McConville C, van der Bijl P, Malcolm K, Augustijns P, Quigley AF, Weiss R, De Haard H, Verrips T (2012). Llama antibody fragments have good potential for application as HIV type 1 topical microbicides.. AIDS Res Hum Retroviruses, 28(2), 198 - 205. doi:10.1089/aid.2011.0133


    • Weiss RA, Vogt PK (2011). 100 years of Rous sarcoma virus.. J Exp Med, 208(12), 2351 - 2355. doi:10.1084/jem.20112160
    • Hale P, Wain-Hobson S, Weiss RA (2011). Vaccine research loses out. NATURE, 478(7368), 188 - 188.
    • Mccoy L, Forsman A, Bulmer-Thomas B, Strokappe N, Verrips T, Chen L, Kwong PD, Weiss RA (2011). Llama Antibody Fragments that Potently Neutralize HIV-1 at the CD4 Binding Site of HIV-1 Gp120.
    • Willey S, Aasa-Chapman MM, O'Farrell S, Pellegrino P, Williams I, Weiss RA, Neil SJ (2011). Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection.. Retrovirology, 8, 16 - . doi:10.1186/1742-4690-8-16
    • Ramsuran V, Kulkarni H, He WJ, Mlisana K, Wright EJ, Werner L, Castiblanco J, Dhanda R, Le T, Dolan MJ, Guan W, Weiss RA, Clark RA, Karim SSA, Ahuja SK, Ndung'u T (2011). Duffy-Null-Associated Low Neutrophil Counts Influence HIV-1 Susceptibility in High-Risk South African Black Women. CLIN INFECT DIS, 52(10), 1248 - 1256. doi:10.1093/cid/cir119
    • Ibañez LI, De Filette M, Hultberg A, Verrips T, Temperton N, Weiss RA, Vandevelde W, Schepens B, Vanlandschoot P, Saelens X (2011). Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection.. J Infect Dis, 203(8), 1063 - 1072. doi:10.1093/infdis/jiq168
    • Hultberg A, Temperton NJ, Rosseels V, Koenders M, Gonzalez-Pajuelo M, Schepens B, Ibanez LI, Vanlandschoot P, Schillemans J, Saunders M, Weiss RA, Saelens X, Melero JA, Verrips CT, Van Gucht S, de Haard HJ (2011). Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules. PLOS ONE, 6(4), - . doi:10.1371/journal.pone.0017665
    • Weiss RA, Hale P (2011). Vaccines: looking back, looking ahead. The Scientist, 25(6), 36 - 37.


    • de Silva T, Weiss RA (2010). HIV-2 goes global: an unaddressed issue in Indian anti-retroviral programmes.. Indian J Med Res, 132, 660 - 662.
    • Wright E, Hayman DT, Vaughan A, Temperton NJ, Wood JL, Cunningham AA, Suu-Ire R, Weiss RA, Fooks AR (2010). Virus neutralising activity of African fruit bat (Eidolon helvum) sera against emerging lyssaviruses.. Virology, 408(2), 183 - 189. doi:10.1016/j.virol.2010.09.014
    • Burton DR, Weiss RA (2010). A Boost for HIV Vaccine Design. SCIENCE, 329(5993), 770 - 773. doi:10.1126/science.1194693
    • Koh WW, Forsman A, Hué S, van der Velden GJ, Yirrell DL, McKnight A, Weiss RA, Aasa-Chapman MM (2010). Novel subtype C human immunodeficiency virus type 1 envelopes cloned directly from plasma: coreceptor usage and neutralization phenotypes.. J Gen Virol, 91(Pt 9), 2374 - 2380. doi:10.1099/vir.0.022228-0
    • Weiss RA (2010). A cautionary tale of virus and disease.. BMC Biol, 8, 124 - . doi:10.1186/1741-7007-8-124
    • Koh WW, Steffensen S, Gonzalez-Pajuelo M, Hoorelbeke B, Gorlani A, Szynol A, Forsman A, Aasa-Chapman MM, de Haard H, Verrips T, Weiss RA (2010). Generation of a family-specific phage library of llama single chain antibody fragments that neutralize HIV-1.. J Biol Chem, 285(25), 19116 - 19124. doi:10.1074/jbc.M110.116699
    • Corti D, Langedijk JPM, Hinz A, Seaman MS, Vanzetta F, Fernandez-Rodriguez BM, Silacci C, Pinna D, Jarrossay D, Balla-Jhagjhoorsingh S, Willems B, Zekveld MJ, Dreja H, O'Sullivan E, Pade C, Orkin C, Jeffs SA, Montefiori DC, Davis D, Weissenhorn W, McKnight A, Heeney JL, Sallusto F, Sattentau QJ, Weiss RA, Lanzavecchia A (2010). Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals. PLOS ONE, 5(1), - . doi:10.1371/journal.pone.0008805
    • Corti D, Suguitan ALJ, Pinna D, Silacci C, Fernandez-Rodriguez BM, Vanzetta F, Santos C, Luke CJ, Torres-Velez FJ, Temperton NJ, Weiss RA, Sallusto F, Subbarao K, Lanzavecchia A (2010). Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine.. Journal of Clinical Investigation, , - . doi:10.1172/JCI41902
    • Hinz A, Hulsik DL, Forsman A, Koh WWL, Belrhali H, Gorlani A, de Haard H, Weiss RA, Verrips T, Weissenhorn W (2010). Crystal Structure of the Neutralizing Llama V-HH D7 and Its Mode of HIV-1 gp120 Interaction. PLOS ONE, 5(5), - . doi:10.1371/journal.pone.0010482


    • Weiss RA (2009). Apes, lice and prehistory.. J Biol, 8(2), 20 - . doi:10.1186/jbiol114
    • Wright E, McNabb S, Goddard T, Horton DL, Lembo T, Nel LH, Weiss RA, Cleaveland S, Fooks AR (2009). A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa.. Vaccine, 27(51), 7178 - 7186. doi:10.1016/j.vaccine.2009.09.024
    • He WJ, Marconi VC, Castiblanco J, Kulkarni H, Clark RA, Dolan MJ, Weiss RA, Ahuja SK (2009). Response: Association of Duffy Antigen Genotypes with HIV-AIDS Susceptibility. CELL HOST MICROBE, 5(5), 418 - 419. doi:10.1016/j.chom.2009.05.007
    • Fooks AR, Johnson N, Freuling CM, Wakeley PR, Banyard AC, McElhinney LM, Marston DA, Dastjerdi A, Wright E, Weiss RA, Muller T (2009). Emerging Technologies for the Detection of Rabies Virus: Challenges and Hopes in the 21st Century. PLOS NEGLECT TROP D, 3(9), - . doi:10.1371/journal.pntd.0000530
    • Weiss RA, Heeney JL (2009). INFECTIOUS DISEASES An ill wind for wild chimps?. NATURE, 460(7254), 470 - 471. doi:10.1038/460470a
    • Kulkarni H, Marconi VC, He WJ, Landrum ML, Okulicz JF, Delmar J, Kazandjian D, Castiblanco J, Ahuja SS, Wright EJ, Weiss RA, Clark RA, Dolan MJ, Ahuja SK (2009). The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry. BLOOD, 114(13), 2783 - 2792. doi:10.1182/blood-2009-04-215186


    • Weiss RA, Wright E, Neil S, Dolan MJ, He W, Kulkarni H, Ahuja S (2008). Duffy Antigen Receptor for Chemokines: a Polymorphism Frequent in Africans that Increases Risk of HIV-1 Infection by 50%.
    • Weiss RA (2008). On viruses, discovery, and recognition.. Cell, 135(6), 983 - 986. doi:10.1016/j.cell.2008.11.022
    • Forsman A, Beirnaert E, Aasa-Chapman MM, Hoorelbeke B, Hijazi K, Koh W, Tack V, Szynol A, Kelly C, McKnight A, Verrips T, de Haard H, Weiss RA (2008). Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120.. J Virol, 82(24), 12069 - 12081. doi:10.1128/JVI.01379-08
    • Forsman A, Weiss RA (2008). Why is HIV a pathogen?. Trends Microbiol, 16(12), 555 - 560. doi:10.1016/j.tim.2008.09.004
    • Weiss RA, UCL Consortium BMGF Collaboration (2008). Novel Broadly Neutralizing Monoclonal Antibodies to HIV-1 Derived from Humans and Llamas.
    • Wright E, Temperton NJ, Marston DA, McElhinney LM, Fooks AR, Weiss RA (2008). Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison. Journal of General Virology, 89, 2204 - 2213. doi:10.1099/vir.0.2008/000349-0
    • He WJ, Neil S, Kulkarni H, Wright E, Agan BK, Marconi VC, Dolan MJ, Weiss RA, Ahujal SK (2008). Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. CELL HOST MICROBE, 4(1), 52 - 62. doi:10.1016/j.chom.2008.06.002
    • Weiss RA (2008). Special anniversary review: twenty-five years of human immunodeficiency virus research: successes and challenges.. Clin Exp Immunol, 152(2), 201 - 210. doi:10.1111/j.1365-2249.2008.03645.x
    • Voisset C, Weiss RA, Griffiths DJ (2008). Human RNA "Rumor" viruses: the search for novel human retroviruses in chronic disease. MICROBIOL MOL BIOL R, 72(1), 157 - +. doi:10.1128/MMBR.00033-07
    • Temperton NJ, Capecchi B, Rappuoli R, de Jong MD, Takeuchi Y, Weiss RA (2008). Measurement of Neutralizing Antibody Responses to Influenza H5N1 Clade 1 A/Viet Nam/1194/04 and Clade 2 A/ Indonesia/5/05 Hemagglutinin Using a Sensitive High Throughput Luciferase- Based Retroviral Pseudotype Assay. In Katz JM (Ed.), Options for the Control of Influenza VI (pp. 94 - 96). : International Medical Press.
    • Weiss RA, Willey S, Aasa-Chapman M, McKnight A (2008). Role of Complement in HIV Infection: A 2-edged Sword?.


    • Weiss RA (2007). Lessons from naked apes and their infections.. Journal of Medical Primatology, 36(4), 172 - 179.
    • Temperton NJ, Hoschler K, Major D, Nicolson C, Manvell R, Hien VM, Ha DQ, de Jong MD, Zambon M, Takeuchi Y, Weiss RA (2007). A sensitive retroviral pseudotype assay for Influenza H5N1 neutralizing antibodies. Influenza and other respiratory viruses, 1(3), 105 - 112. doi:10.1111/j.1750-2659.2007.00016.x
    • Bassett JHD, O'Shea PJ, Sriskantharajah S, Rabier B, Boyde A, Howell PGT, Weiss RE, Roux J-P, Malaval L, Clement-Lacroix P, Samarut J, Chassande O, Williams GR (2007). Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism. Molecular Endocrinology, 21(5), 1095 - 1107. doi:10.1210/me.2007-0033
    • Weiss RA (2007). Lessons from naked apes and their best friends. J MED PRIMATOL, 36(4-5), 286 - 286.


    • Ahuja SK, Aiuti F, Berkhout B, Biberfeld P, Burton DR, Colizzi V, Deeks SG, Desrosiers RC, Dierich MP, Doms RW, Emerman M, Gallo RC, Girard M, Greene WC, Hoxie JA, Hunter E, Klein G, Korber B, Kuritzkes DR, Lederman MM, Malim MH, Marx PA, McCune JM, McMichael A, Miller C, Miller V, Montagnier L, Montefiori DC, Moore JP, Nixon DF, Overbaugh J, Pauza CD, Richman DD, Saag MS, Sattentau Q, Schooley RT, Shattock R, Shaw GM, Stevenson M, Trkola A, Wainberg MA, Weiss RA, Wolinsky S, Zack JA (2006). A plea for justice for jailed medical workers.. Science, 314(5801), 924 - 925.
    • Newton R, Carpenter L, Casabonne D, Beral V, Babiker A, Darbyshire J, Weller I, Weiss R, Kwan A, Bourboulia D, Munoz F, Lagos D, Boshoff C (2006). A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1. BRITISH JOURNAL OF CANCER, 94(10), 1504 - 1509. doi:10.1038/sj.bjc.6603100
    • Weiss RA (2006). What have oncogenic viruses taught us?.
    • Weiss RA, Fassati A, Murgia C (2006). A sexually transmitted parasitic cancer. RETROVIROLOGY, 3, - .
    • Kellam P, Weiss RA (2006). Infectogenomics: Insights from the host genome into infectious diseases.. Cell, 124, 695 - 697.
    • Heeney JL, Dalgleish AG, Weiss RA (2006). Origins of HIV and the evolution of resistance to AIDS. Science, 313, 462 - 466.
    • Weiss RA (2006). The discovery of endogenous retroviruses. Retrovirology, 3(67), - . doi:10.1186/1742-4690-3-67
    • Murgia C, Pritchard JK, Kim SY, Fassati A, Weiss RA (2006). Clonal origin and evolution of a transmissible cancer.. Cell, 126(3), 477 - 487. doi:10.1016/j.cell.2006.05.051


    • Neil SJ, McKnight A, Gustafsson KT, Weiss RA (2005). HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation. Blood, 105(12), 4693 - 4699. doi:10.1182/blood-2004-11-4267
    • Weiss RA (2005). Robert Koch: The grandfather of cloning?. Cell, 123, 539 - 542.
    • Temperton NJ, Chan PK, Simmons G, Zambon MC, Tedder RS, Takeuchi Y, Weiss RA (2005). Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes.. Emerging Infectious Diseases, 11(3), 411 - 416.
    • Neil SJ, Aasa-Chapman MMI, Clapham PR, Nibbs RJ, McKnight A, Weiss RA (2005). The promiscuous CC chemokine receptor D6 is a functional coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and HIV-2 on astrocytes. Journal of Virology, 79, 9618 - 9624. doi:10.1128/jvi.79.15.9618-9624.2005
    • McLean AR, May RM, Pattison JM, Weiss RA (2005). SARS: A case study in emerging infections..


    • Bartosch B, Stefanidis D, Myers R, Weiss RA, Patience C, Takeuchi Y (2004). Evidence and consequence of porcine endogenous retrovirus recombination. Journal of Virology, 78(24), 13880 - 13890. doi:10.1128/JVI.78.24.13880-13890.2004
    • Magre S, Takeuchi Y, Langford G, Richards A, Patience C, Weiss RA (2004). Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope. Journal of Virology, 78(11), 5812 - 5819.
    • Weiss RA (2004). Circe, Cassandra and the Trojan pigs: xenotransplantation. Proceedings of the American Philosophical Society, 148, 281 - 295.
    • Weiss RA (2004). Editorial: Multistage carcinogenesis. British Journal of Cancer, 91, 1981 - 1982.
    • Weiss RA, McMichael AJM (2004). Social and environmental risk factors in the emergence of infectious diseases. Nature Medicine, 10, S70 - S76.
    • McLean AR, May RM, Pattison J, Weiss RA (2004). Emerging infections: what have we learnt from SARS? Papers of a Discussion Meeting held at The Royal Society on 13 January 2004 - Introduction. PHILOS T R SOC B, 359(1447), 1047 - 1048. doi:10.1098/rstb.2004.1488
    • Weiss RA (2004). Cancer, infection and immunity: a personal homage to Jan Svoboda.. Folia Biol (Praha), 50(3-4), 78 - 86.
    • Bhattacharya B, Weiss RA, Davis C, Holmes H, Hockley D, Fassati A (2004). Detection and quantitation of human imunodeficiency virus type-1 particles by confocal microscopy. Journal of Virological Methods, 120(1), 13 - 21.
    • Bhattacharya B, Weiss RA, Davis C, Holmes H, Hockley D, Fassati A (2004). Detection and quantitation of human immunodeficiency virus type-1 particles by confocal microscopy. J VIROL METHODS, 120(1), 13 - 21. doi:10.1016/j.viromet.2004.03.019
    • Weiss RA, McLean AR (2004). What have we learnt from SARS?. Philosophical Transactions of the Royal Society B: Biological Sciences, 359(1447), 1137 - 1140.
    • Weiss RA, Dalgleish AG, Loveday C, Pillay D (2004). Immunodeficiency viruses. In Zuckerman AJ, Banatvala JE, Pattison JR, Griffiths PD, Schoub BD (Ed.), Principles and Practice of Clinical Virology (pp. 721 - 757). : John Wiley and Sons Ltd.


    • Jenner RG, Maillard K, Cattini N, Weiss RA, Boshoff C, Wooster R, Kellam P (2003). Kaposi's sarcoma-associated herpes virus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proceedings of the National Academy of Sciences of the United States of America, 100(18), 10399 - 10404. doi:10.1073/pnas.1630810100
    • Weiss RA (2003). Cross-species infections.. Curr Top Microbiol Immunol, 278, 47 - 71.
    • Weiss RA (2003). Human receptors for retroviruses. In Sugumura K, Uchiyama T, Matsuoka M, Kannagi M (Ed.), Gann Monograph on Cancer Research No 50: Two decades of adult T-cell leukaemia and HTLV-1 research (pp. - ). : Japan Scientific Societies Press.
    • Weiss RA (2003). Family heirlooms and new acquisitions: the origins of human viruses.
    • Weiss RA (2003). Host genetic polymorphisms and HIV infection.
    • Weiss RA (2003). HIV and AIDS in relation to other pandemics. Among the viruses plaguing humans, HIV is a recent acquisition. Its outstanding success as an infection poses immense scientific challenges to human health and raises the question "What comes nest?".. EMBO Rep, 4 Spec No, S10 - S14. doi:10.1038/sj.embor.embor857
    • Weiss RA (2003). Response from Weiss: Evolution of virulence: adaptive or not?. TRENDS MICROBIOL, 11(3), 113 - 114. doi:10.1016/S0966-843X(03)00022-2
    • McKnight A, Weiss RA (2003). Blocking the docking of HIV-1. Proceedings of the National Academy of Sciences of the United States of America, 100, 10581 - 10582.
    • Newton R, Ziegler J, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C (2003). Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda. British Journal of Cancer, 89(3), 502 - 504.
    • Newton R, Ziegler J, Bourboulia D, Casaborne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C (2003). The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda. International Journal of Cancer, 103(2), 226 - 232.
    • Thomas ER, Shotton C, Weiss RA, Clapham PR, McKnight A (2003). CD4-dependent and CD4-independent HIV-2: consequences for neutralization. AIDS, 17, 291 - 300.
    • Weiss RA (2003). Cross-species infections. Current Topics in Microbiology and Immunology, 278, 48 - 71.
    • Weiss RA (2003). HIV and AIDS in relation to other pandemics. EMBO Reports, 4, S10 - S14.
    • Weiss RA (2003). HIV and AIDS: looking ahead. Nature Medicine, 9, 887 - 891.
    • Ziegler J, Newton R, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C (2003). Risk factors for Kaposi's sarcoma: A case-control study of HIV- seronegative people in Uganda. International Journal of Cancer, 103(2), 233 - 240.
    • Ericksson TA, Takeuchi Y, Templin C, Quinn G, Farhadian SF, Wood JC, Oldmixon BA, Suling KM, Ishii JK, Kitagawa Y, Miyazawa Y, Salomon DR, Weiss RA, Patience C (2003). Identification of receptors for pig endogenous retrovirus. Proceedings of the National Academy of Sciences of the United States of America, 100(11), 6759 - 6764. doi:10.1073/pnas.1138025100


    • Weiss RA (2002). Virulence and pathogenesis. Trends in Microbiology, 10, 314 - 317.
    • Weiss RA (2002). HIV receptors and cellular tropism.. IUBMB Life, 53(4-5), 201 - 205. doi:10.1080/15216540212652
    • Weiss RA (2002). HIV receptors and cellular tropism. IUBMB LIFE, 53(4-5), 201 - 205. doi:10.1080/15216540290098927
    • Weiss RA (2002). Hepatitis B - The hunt for a killer virus. SCIENCE, 297(5590), 2213 - 2213.
    • Wilkinson J, Cope A, Gill J, Bourboulia D, Hayes P, Imami N, Kubo T, Marcelin A, Calvez V, Weiss R, Gazzard B, Boshoff C, Gotch F (2002). Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-infected patients receiving highly active antiretr. Journal of Virology, 76(6), 2634 - 2640.
    • Bartosch B, Weiss RA, Takeuchi Y (2002). PCR-based cloning and immuncytological titration of infectious porcine endogenous retrovirus subgroup A and B. Journal of General Virology, 83(pt 9), 2231 - 2240.
    • Boshoff C, Weiss RA (2002). AIDS-related malignancies. Nature Reviews Cancer, 2, 373 - 382.
    • Weiss RA (2002). Reflections on the origin of human immunodeficiency viruses. AIDS and Hepatitis Digest, 87, 2 - 4.
    • Weiss RA (2002). Xenotransplantation: promise and problems. In Brooks G (Ed.), Gene Therapy: the use of DNA as a drug (pp. 295 - 312). : Pharmaceutical Press.
    • Griffiths DJ, Voisset C, Venables PJ, Weiss RA (2002). Novel endogenous retrovirus in rabbits previously reported as human retrovirus 5. Journal of Virology, 76(14), 7094 - 7102. doi:10.1128/jvi.76.14.7094-7102.2002


    • Weiss RA (2001). HIV: Polio vaccines exonerated. Nature, 410(6832), 1035 - 1036.
    • Weiss RA (2001). Polio vaccines exonerated. NATURE, 410(6832), 1035 - 1036.
    • Weiss RA (2001). Gulliver's travels in HIVland. Nature, 410(6831), 963 - 967.
    • Boshoff C, Weiss R (2001). Cancer processes in immunodeficient populations: an introduction. European Journal of Cancer, 37, 1202 - 1208.
    • Boshoff C, Weiss RA (2001). Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philosophical Transactions of the Royal Society B: Biological Sciences, 356(1408), 517 - 534.
    • Davidovici B, Karakis I, Bourboulia D, Ariad S, Zong JC, Benharroch D, Dupin N, Weiss R, Hayward G, Sarov B, Boshoff C (2001). Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. Journal of the National Cancer Institute, 93(3), 194 - 202. doi:10.1093/jnci/93.3.194
    • Patience C, Takeuchi Y, Cosset FL, Weiss RA (2001). MuLV packaging systems as models for estimating/measuring retrovirus recombination frequency. Developmental Biology, 106, 169 - 179.
    • Patience C, Switzer WM, Takeuchi Y, Griffiths DJ, Goward ME, Heneine W, Stoye JP, Weiss RA (2001). Multiple groups of novel retroviral genomes in pigs and related species. Journal of Virology, 75(6), 2771 - 2775. doi:10.1128/jvi.75.6.2771-2775.2001
    • Weiss RA (2001). Heterosexual transmission of HIV-1 infection in UK - Reply. LANCET, 358(9291), 1458 - 1458.
    • Hale P, Makgoba MW, Merson MH, Quinn TC, Richman DD, Vella S, Wabwire-Mangen F, Wain-Hobson S, Weiss RA (2001). Success hinges on support for treatment. NATURE, 412(6844), 272 - 272.
    • Weiss RA (2001). Natural and iatrogenic factors in human immunodeficiency virus transmission. Philosophical Transactions of the Royal Society B: Biological Sciences, 356(1410), 947 - 953.
    • Weiss RA (2001). The Leeuwenhoek Lecture 2001. Animal origins of human infectious disease. Philosophical Transactions of the Royal Society B: Biological Sciences, 356(1410), 957 - 977.
    • Weiss RA (2001). Shots in the dark - The wayward search for an AIDS vaccine. SCIENCE, 292(5518), 862 - 863.
    • Weiss RA, Adler MW, Rowland-Jones SL (2001). The changing face of HIV and AIDS.
    • Epstein MA, Rickinson AB, Weiss RA (2001). Oncogenic g-herpesviruses: an expanding family.
    • Kellam P, Weiss RA (2001). How technology drives pathogen discovery. Microbiology Today, (28), 16 - 17.
    • Linial M, Weiss RA (2001). Other human and primate retroviruses. In Knipe DM, Howley PM (Ed.), Field Virology (pp. 2123 - 2139). : Lippincott Williams and Wilkins.
    • Pizzato M, Blair ED, Fling M, Kopf J, Tomassetti A, Weiss RA, Takeuchi Y (2001). Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells. Gene Therapy, 8(14), 1088 - 1096.
    • Qari SH, Magre S, Garcia-Lerma JG, Hussain AI, Takeuchi Y, Patience C, Weiss RA, Heneine W (2001). Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitors. Journal of Virology, 75(2), 1048 - 1053.
    • Weiss RA (2001). Adventitious viral genomes in vaccines but not in vaccinees. Emerging Infectious Diseases, 7(1), 153 - 154.
    • Weiss RA (2001). Retroviruses and cancer. Current Science, 81(5), 528 - 534.
    • Weiss RA (2001). Retroviruses and xenotransplantation. In Platt JL (Ed.), Xenotransplantation (pp. 239 - 250). : ASM Press.
    • Weiss RA (2001). Comparative retroviology and cross-species transmission. AIDS RES HUM RETROV, 17, S12 - S12.
    • Griffiths DJ, Venables PJW, Weiss RA (2001). Human retrovirus-5: an envelope-deficient retrovirus?. AIDS RES HUM RETROV, 17, S17 - S17.


    • Whitby D, Luppi M, Sabin C, Barozzi P, Di Biase AR, Balli F, Cucci F, Weiss RA, Boshoff C, Torelli G (2000). Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission. British Journal of Cancer, 82(3), 702 - 704.
    • Weiss RA (2000). Virus: The co-discoverer of HIV tracks its rampage and charts the future. NATURE, 405(6784), 277 - 278.
    • Weiss RA (2000). Certain promise and uncertain peril - The debate on xenotransplantation. EMBO REP, 1(1), 2 - 4. doi:10.1093/emborep.kvd017
    • Weiss RA (2000). Getting to know HIV.. Trop Med Int Health, 5(7), A10 - A15.
    • Weiss RA (2000). Certain promise and uncertain peril. The debate on xenotransplantation. EMBO Reports, 1(1), 2 - 4.
    • Takeuchi Y, Weiss RA (2000). Xenotransplantation: reappraising the risk of retroviral zoonosis. CURR OPIN IMMUNOL, 12(5), 504 - 507.
    • Takeuchi Y, Weiss RA (2000). Xenotransplantation: reappraising the risk of retroviral zoonosis. Current Opinion in Immunology, 12(5), 504 - 507.
    • Weiss RA (2000). Xenotransplantation: pausing to reflect.. Hosp Pract (1995), 35(10), 71 - 78.
    • Wain-Hobson S, Weiss RA (2000). If free speech costs lives that's a high price to pay. NATURE, 407(6806), 834 - 834.
    • Weiss RA (2000). Ancient and modern retroviruses.. Acta Microbiol Immunol Hung, 47(4), 403 - 410.
    • Rosenblum LL, Weiss RA, McClure MO (2000). Virus load and sequence variation in simian retrovirus type 2 infection. Journal of Virology, 74(8), 3449 - 3454.
    • Weiss RA, Magre S, Takeuchi Y (2000). Infection hazards of xenotransplantation.. J Infect, 40(1), 21 - 25. doi:10.1053/jinf.1999.0604
    • Morozov VA, Lagaye S, Taylor GP, Matutes E, Weiss RA (2000). Chimeric matrix proteins encoded by defective proviruses with large internal deletions in human T-cell leukemia virus type 1-infected humans. Journal of Virology, 74(9), 3933 - 3940.
    • Weiss RA (2000). Retroviruses and Cancer. In Goedert JJ (Ed.), Infectious Causes of Cancer (pp. 197 - 210). : Humana Press, Totowa, New Jersey.
    • Weiss R, Boshoff C (2000). Addressing controversies over Kaposi's sarcoma. Journal of the National Cancer Institute, 92(9), 677 - 679.
    • Dupin N, Diss T, Kellam P, Tulliez M, Du MQ, Sicard D, Weiss RA, Isaacson PG, Boshoff C (2000). HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. BLOOD, 95(4), 1406 - 1412.


    • Weiss RA (1999). Xenografts and retroviruses.. Science, 285(5431), 1221 - 1222.
    • Boshoff C, Weiss RA (1999). Introduction. Semin Cancer Biol, 9(3), 149 - 150. doi:10.1006/scbi.1999.0120
    • Boshoff C, Weiss RA (1999). HHV8/KSHV - Introduction. SEMIN CANCER BIOL, 9(3), 149 - 150.
    • Talbot SJ, Weiss RA, Kellam P, Boshoff C (1999). Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line.. Virology, 257(1), 84 - 94.
    • Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, van Marck E, Salmon D, Gorin I, Escande JP, Weiss RA, Alitalo K, Boshoff C (1999). Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma.. Proc Natl Acad Sci U S A, 96(8), 4546 - 4551.
    • Smith NA, Sabin CA, Gopal R, Bourboulia D, Labbet W, Boshoff C, Barlow D, Band B, Peters BS, de Ruiter A, Brown DW, Weiss RA, Best JM, Whitby D (1999). Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. The Journal of Infectious Diseases, 180(3), 600 - 606.
    • Kellam P, Bourboulia D, Dupin N, Shotton C, Fisher C, Talbot S, Boshoff C, Weiss RA (1999). Characterization of monoclonal antibodies raised against the latent nuclear antigen of human herpesvirus 8.. J Virol, 73(6), 5149 - 5155.
    • Weiss RA (1999). Viruses, cancer and AIDS.. FEMS Immunol Med Microbiol, 26(3-4), 227 - 232.
    • Weiss RA (1999). The river - A journey to the source of HIV and AIDS. SCIENCE, 286(5443), 1305 - 1306.
    • Weiss RA, Griffiths D, Takeuchi Y, Patience C, Venables PJW (1999). Retroviruses: ancient and modern. ARCH VIROL, , 171 - 177.
    • Weiss RA, Wrangham RW (1999). From Pan to pandemic. NATURE, 397(6718), 385 - 386.
    • Weiss RA (1999). Biomedicine - Xenografts and retroviruses. SCIENCE, 285(5431), 1221 - 1222.


    • Patience C, Takeuchi Y, Cosset FL, Weiss RA (1998). Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells. Journal of Virology, 72(4), 2671 - 2676.
    • Patience C, Patton GS, Takeuchi Y, Weiss RA, McClure MO, Rydberg L, Breimer ME (1998). No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. The Lancet, 352(9129), 699 - 701.
    • Takeuchi Y, Patience C, Magre S, Weiss RA, Banerjee PT, Le Tissier P, Stoye JP (1998). Host range and interference studies of three classes of pig endogenous retrovirus. Journal of Virology, 72(12), 9986 - 9991.


    • Howard MR, Whitby D, Bahadur G, Suggett F, Boshoff C, Tenant-Flowers M, Schulz TF, Kirk S, Matthews S, Weller IVD, Tedder RS, Weiss RA (1997). Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. AIDS, 11, F15 - F19.
    • Dittmar MT, Simmons G, Hibbitts S, OHare M, Louisirirotchanakul S, Beddows S, Weber J, Clapham PR, Weiss RA (1997). Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups. J VIROL, 71(10), 8008 - 8013.
    • Boshoff C, Endo Y, Collins PD, Takeuchi Y, Reeves JD, Schweickart VL, Siani MA, Sasaki T, Williams TJ, Gray PW, Moore PS, Chang Y, Weiss RA (1997). Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science, 278(5336), 290 - 294.
    • Patience C, Takeuchi Y, Weiss RA (1997). Infection of human cells by an endogenous retrovirus of pigs. Nature Medicine, 3(3), 282 - 286.
    • Le Tissier P, Stoye JP, Takeuchi Y, Patience C, Weiss RA (1997). Two sets of human-tropic pig retrovirus. Nature, 389(6652), 681 - 682.
    • Takeuchi Y, Liong SH, Bieniasz PD, Jager U, Porter CD, Friedman T, McClure MO, Weiss RA (1997). Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylation. Journal of Virology, 71(8), 6174 - 6178.
    • Weiss RA, Kellam P (1997). Illicit viral DNA.. Nature, 390(6657), 235 - 236.
    • Kellam P, Boshoff C, Whitby D, Matthews S, Weiss RA, Talbot SJ (1997). Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome.. Journal of Human Virology, 1(1), 19 - 29.


    • Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, deRuiter A, Hatzakis A, Tedder RS, Weller IVD, Weiss RA, Moore PS (1996). Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. LANCET, 348(9035), 1133 - 1138.
    • Takeuchi Y, Porter CD, Strahan KM, Preece AF, Gustafsson K, Cosset FL, Weiss RA, Collins MK (1996). Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase. Nature, 379(6560), 85 - 88.
    • Porter CD, Collins MKJ, Tailor CS, Parkar MH, Cossett F-L, Weiss RA, Takeuchi Y (1996). Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors. Human Gene Therapy, 7, 913 - 919.


    • McKnight A, Weiss RA, Shotton C, Takeuchi Y, Hoshino H, Clapham PR (1995). Change in tropism upon immune escape by human immunodeficiency virus. Journal of Virology, 69, 3167 - 3170.
    • Cosset FL, Takeuchi Y, Battini JL, Weiss RA, Collins MK (1995). High-titer packaging cells producing recombinant retroviruses resistant to human serum. Journal of Virology, 69(12), 7430 - 7436.
    • Cosset FL, Morling FJ, Takeuchi Y, Weiss RA, Collins MK, Russell SJ (1995). Retroviral retargeting by envelopes expressing an N-terminal binding domain. Journal of Virology, 69(10), 6314 - 6322.


    • Takeuchi Y, Cosset FL, Lachmann PJ, Okada H, Weiss RA, Collins MK (1994). Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. Journal of Virology, 68(12), 8001 - 8007.


    • Tailor CS, Takeuchi Y, O'Hara B, Johann SV, Weiss RA, Collins MK (1993). Mutation of amino acids within the gibbon ape leukemia virus (GALV) receptor differentially affects feline leukemia virus subgroup B, simian sarcoma-associated virus, and GALV infections. Journal of Virology, 67(11), 6737 - 6741.


    • Takeuchi Y, Vile RG, Simpson G, O'Hara B, Collins MK, Weiss RA (1992). Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus. Journal of Virology, 66(2), 1219 - 1222.










    • Weiss RA (1971). Cell transformation induced by Rous sarcoma virus: analysis of density dependence.. Virology, 46(2), 209 - 220.